Veracyte (VCYT) shares ended the last trading session 13.2% higher at $25.56. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 5.7% gain over the past four weeks.Last month, Veracyte presented new data suggesting the potential of novel molecular signatures to identify patients with thyroid nodules or cancer who have aggressive disease. The results, derived using its Afirma GRID (Genomic Resource for Intelligent Disc ...